Kwok Pang, COO, Autolomous, London, UK, describes practical efforts in implementing real-time data analysis to optimize the value chain in the cell and gene therapy (CGT) space. Processing the data in real-time enables manufacturing processes to be scaled-up as decisions can be made instantaneously. Manufacturing costs can additionally be lowered as a result, where increased density of the relevant infrastructure in a given area can increase efficiency. This interview took place at Advanced Therapies Week 2022.